Heron Therapeutics Inc vs iShares International Treasury Bond ETF — how do they compare? Heron Therapeutics Inc trades at $0.33 (market cap $61.47M), while iShares International Treasury Bond ETF trades at $41.13. The key difference: iShares International Treasury Bond ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | IGOV | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | — |
52-Week High | $1.49 | $43.09 |
52-Week Low | $0.32 | $40.35 |
Enterprise Value | $168.21M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →